FDA Updates COVID-19 Digital Health Policies And Public Health Solutions
Most software and apps not regulated as devices by agency
Executive Summary
The US Food and Drug Administration’s update includes the agency’s current policies that may support public health innovation in COVID-19-related digital health technologies and the response to the ongoing public health emergency.
You may also be interested in...
Medicare Proposes NTAP For Breakthrough Treatment Of Spinal Condition
US Medicare has granted a new technology add-on payment (NTAP) for an innovative technology designed to treat adult spinal deformity.
First EUA In US For OTC Test To Detect COVID-19, Flu, RSV Granted To Labcorp
Agency issued an emergency use authorization to Labcorp for its OTC that detects COVID-19, flu and respiratory syncytial virus.
Senate Bill Establishes Greater Regulatory Oversight Of Lab Developed Tests
Draft legislation out of the US Senate Health, Education, Labor and Pensions (HELP) Committee gives the FDA authority to regulate certain in vitro diagnostics known as laboratory developed tests.